Insulin Efsitora Alfa Demonstrates A1C Reduction in Various Clinical Trials
Once-weekly efsitora alfa shows promising hemoglobin A1C reduction in type 2 diabetes (T2D), simplifying insulin therapy and reducing injection frequency significantly.
Related Articles
Follow-Up Study Confirms Omlyclo Biosimilarity to Xolair in Treatment of CSU
The biosimilar showed similar efficacy, pharmacokinetics, pharmacodynamics, safety, quality of life, and immunogenicity in patients with chronic spontaneous urticaria (CSU).
Annals of Internal Medicine: Multimedia
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
HIV Reporting Meets the Front Line: How Pharmacists Translate Global Health Into Local Care
Pharmacists play a vital role in translating global health news into actionable knowledge for their communities.
Novel biallelic splicing and deletion variants of ADAMTS3 found in adult patients with Hennekam lymphangiectasia-lymphedema syndrome 3
Background ADAM metallopeptidase with thrombospondin type 1 motif 3 ( ADAMTS3) is one of the causative genes for the Hennekam lymphangiectasia-lymphedema syndrome (HKLLS), an autosomal…
Study Finds Higher BMI Increases Breast Cancer Risk in Women With Heart Conditions
Research reveals that higher BMI in women with cardiovascular disease significantly increases breast cancer risk, highlighting the need for targeted prevention strategies.
Trump eyes steep pharma tariffs, threatening higher drug costs and shortages
New tariffs of up to 200% could hit medications from the European Union and beyond, raising alarms over affordability, access and supply for physicians and…
Study Finds Higher BMI Increases Breast Cancer Risk in Women With Heart Conditions
Research reveals that higher BMI in women with cardiovascular disease significantly increases breast cancer risk, highlighting the need for targeted prevention strategies.
Parvalbumin expression identifies subicular principal cells with high projection specificity
Neocortex pyramidal cells with specific projection targets have been reported to express parvalbumin. Baccini et al. report that parvalbumin expression also marks two subclasses of…
Enzalutamide Plus Leuprolide Extends Survival in High-Risk Non-Metastatic Prostate Cancer
Enzalutamide combined with leuprolide significantly enhances survival in high-risk non-metastatic prostate cancer, marking a breakthrough in treatment strategies.